Clinical Trials
3 trialsNCT03335540 2022-09-26
ADVISE
Bristol-Myers Squibb
Phase 1 Completed
NCT03343613 2020-06-09
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
NCT01822691 2016-01-18
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed